Jenny Freeman, Terry Gorst, Jodielin Ofori, Jonathan Marsden
{"title":"多发性硬化症痉挛量表88的评估:一个简短的报告。","authors":"Jenny Freeman, Terry Gorst, Jodielin Ofori, Jonathan Marsden","doi":"10.1177/1179572718823510","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity.</p><p><strong>Objective: </strong>To evaluate the convergent validity and responsiveness of the MSSS-88.</p><p><strong>Design: </strong>Longitudinal study.</p><p><strong>Setting: </strong>University Laboratory.</p><p><strong>Subjects: </strong>Thirty-four people with multiple sclerosis.</p><p><strong>Methods: </strong>People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the clinician-rated Ashworth Scale, and a laboratory-based measure of ankle spasticity. Spasticity measure responsiveness was evaluated in 20 participants at two time points, an average of 8.75 ± 3.8 months apart.</p><p><strong>Results: </strong>In people with MS (mean age 55.1 ± 8.1 years; Expanded Disability Scale range 4.5-7.0), spasticity symptom specific subscales of the MSSS-88 (stiffness and spasms) showed strong and significant correlations with the clinician-rated Ashworth Scale (<i>r</i> = 0.52-0.53; <i>P</i> < .01). Responsiveness of the MSSS-88 was comparable to a laboratory-based measure of ankle spasticity.</p><p><strong>Conclusions: </strong>Our findings lend additional support to the convergent validity of this measure.</p>","PeriodicalId":41347,"journal":{"name":"Rehabilitation Process and Outcome","volume":"8 ","pages":"1179572718823510"},"PeriodicalIF":2.3000,"publicationDate":"2019-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179572718823510","citationCount":"2","resultStr":"{\"title\":\"Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report.\",\"authors\":\"Jenny Freeman, Terry Gorst, Jodielin Ofori, Jonathan Marsden\",\"doi\":\"10.1177/1179572718823510\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity.</p><p><strong>Objective: </strong>To evaluate the convergent validity and responsiveness of the MSSS-88.</p><p><strong>Design: </strong>Longitudinal study.</p><p><strong>Setting: </strong>University Laboratory.</p><p><strong>Subjects: </strong>Thirty-four people with multiple sclerosis.</p><p><strong>Methods: </strong>People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the clinician-rated Ashworth Scale, and a laboratory-based measure of ankle spasticity. Spasticity measure responsiveness was evaluated in 20 participants at two time points, an average of 8.75 ± 3.8 months apart.</p><p><strong>Results: </strong>In people with MS (mean age 55.1 ± 8.1 years; Expanded Disability Scale range 4.5-7.0), spasticity symptom specific subscales of the MSSS-88 (stiffness and spasms) showed strong and significant correlations with the clinician-rated Ashworth Scale (<i>r</i> = 0.52-0.53; <i>P</i> < .01). Responsiveness of the MSSS-88 was comparable to a laboratory-based measure of ankle spasticity.</p><p><strong>Conclusions: </strong>Our findings lend additional support to the convergent validity of this measure.</p>\",\"PeriodicalId\":41347,\"journal\":{\"name\":\"Rehabilitation Process and Outcome\",\"volume\":\"8 \",\"pages\":\"1179572718823510\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2019-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1179572718823510\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rehabilitation Process and Outcome\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1179572718823510\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"REHABILITATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rehabilitation Process and Outcome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179572718823510","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"REHABILITATION","Score":null,"Total":0}
Evaluation of the Multiple Sclerosis Spasticity Scale 88: A Short Report.
Background: The Multiple Sclerosis Spasticity Scale 88 (MSSS-88) is designed to capture the patient experience and impact of spasticity, but there is limited evaluation against clinician-rated measures of spasticity.
Objective: To evaluate the convergent validity and responsiveness of the MSSS-88.
Design: Longitudinal study.
Setting: University Laboratory.
Subjects: Thirty-four people with multiple sclerosis.
Methods: People with multiple sclerosis (MS; n = 34) completed the self-reported 12-item Multiple Sclerosis Walking Scale, Multiple Sclerosis Spasticity Scale, Barthel Index alongside the clinician-rated Ashworth Scale, and a laboratory-based measure of ankle spasticity. Spasticity measure responsiveness was evaluated in 20 participants at two time points, an average of 8.75 ± 3.8 months apart.
Results: In people with MS (mean age 55.1 ± 8.1 years; Expanded Disability Scale range 4.5-7.0), spasticity symptom specific subscales of the MSSS-88 (stiffness and spasms) showed strong and significant correlations with the clinician-rated Ashworth Scale (r = 0.52-0.53; P < .01). Responsiveness of the MSSS-88 was comparable to a laboratory-based measure of ankle spasticity.
Conclusions: Our findings lend additional support to the convergent validity of this measure.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
